Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023

BUY
$98.98 - $115.74 $32,663 - $38,194
330 Added 1.04%
31,961 $3.7 Million
Q2 2023

Aug 09, 2023

SELL
$96.34 - $112.38 $22.1 Million - $25.8 Million
-229,819 Reduced 87.9%
31,631 $3.25 Million
Q1 2023

May 10, 2023

SELL
$107.32 - $113.5 $7.57 Million - $8 Million
-70,517 Reduced 21.24%
261,450 $28.5 Million
Q4 2022

Feb 06, 2023

BUY
$62.39 - $113.8 $18.7 Million - $34.2 Million
300,353 Added 950.06%
331,967 $37.8 Million
Q3 2022

Nov 07, 2022

BUY
$58.92 - $84.67 $34,232 - $49,193
581 Added 1.87%
31,614 $1.98 Million
Q2 2022

Aug 04, 2022

SELL
$79.4 - $116.36 $183,255 - $268,558
-2,308 Reduced 6.92%
31,033 $2.48 Million
Q1 2022

May 10, 2022

SELL
$86.42 - $109.81 $4,925 - $6,259
-57 Reduced 0.17%
33,341 $3.51 Million
Q4 2021

Feb 10, 2022

SELL
$98.56 - $119.91 $146,755 - $178,545
-1,489 Reduced 4.27%
33,398 $3.6 Million
Q3 2021

Nov 09, 2021

BUY
$91.91 - $110.37 $40,440 - $48,562
440 Added 1.28%
34,887 $3.82 Million
Q2 2021

Aug 11, 2021

BUY
$86.24 - $95.92 $153,679 - $170,929
1,782 Added 5.46%
34,447 $3.45 Million
Q1 2021

May 14, 2021

SELL
$71.83 - $95.48 $62,492 - $83,067
-870 Reduced 2.59%
32,665 $3.01 Million
Q4 2020

Feb 16, 2021

SELL
$67.0 - $84.39 $933,176 - $1.18 Million
-13,928 Reduced 29.34%
33,535 $2.45 Million
Q3 2020

Nov 10, 2020

BUY
$55.23 - $79.93 $71,799 - $103,909
1,300 Added 2.82%
47,463 $3.69 Million
Q2 2020

Aug 13, 2020

BUY
$30.2 - $56.98 $1.39 Million - $2.63 Million
46,163 New
46,163 $2.57 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.